PubmedID,Title,Publication Date,Non-academicAuthor(s),CompanyAffiliation(s),Corresponding Author Email
40260289,Immunophenotyping of colon cancer for identification of potential antigens for colon cancer vaccines.,2025,Keyi Wei; Jing Yang,"Department of Gastroenterology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.; Department of Gastroenterology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.",Not Found
40256901,Cholesterol-Derived Mannosylated Polypeptide-Formed Lipid Nanoparticles for Efficient in Vivo mRNA Delivery.,2025,Not Found,Not Found,Not Found
40256582,"First Malaria Vaccine RTS, S: A Step toward the Eradication of Malaria.",2024,Not Found,Not Found,Not Found
40256120,Shared neoantigens for cancer immunotherapy.,2025,Not Found,Not Found,Not Found
40254200,Immmunoinformatics-based design of T and B-cell multi-epitope vaccine to combat Borrelia burgdorferi infection.,2025,Zhiqiang Chen; Xun Huang; Liangyu Zhu; Bingxue Li; Yanhong Wang; Hanxin Wu; Li Peng; Weijie Ma; Lei Zhong; Rui Yang; Weijiang Ma; Li Gao; Xinya Wu; Jieqin Song; Jiaru Yang; Ruian Bao; Zida Zheng; Suyi Luo; Aihua Liu; Fukai Bao,"Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China; Department of Pathology, People's Hospital of Fengjie, Fengjie, Chongqing 404600, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China; Department of Microbiology and Immunology, Haiyuan College, Kunming Medical University, Kunming 650101, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China. Electronic address: liuaihua@kmmu.edu.cn.; Yunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China; Department of Microbiology and Immunology, Haiyuan College, Kunming Medical University, Kunming 650101, China. Electronic address: baofukai@kmmu.edu.cn.",liuaihua@kmmu.edu.cn.
40251380,Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice.,2025,Not Found,Not Found,zhangxiaoyan@fudan.edu.cn.
40251187,Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens.,2025,Not Found,Not Found,skent@unimelb.edu.au.
40250463,"Defining the serotypes of SARS-CoV-2 subvariants up to December, 2024.",2025,Not Found,Not Found,wangqihui@im.ac.cn.
40249391,The therapeutic effect of mRNA vaccines in glioma: a comprehensive review.,2025,Not Found,Not Found,Not Found
40249308,Re-imagining combination vaccines for travel medicine.,2025,Not Found,Not Found,@
40248714,mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients.,2025,Bethany Girard; Amparo L Figueroa; Dina Stolman; Uma Siangphoe; Elizabeth de Windt; Jacqueline M Miller; Rituparna Das; Frances Priddy,"Moderna, Inc., Cambridge, MA, United States.; Moderna, Inc., Cambridge, MA, United States.; Moderna, Inc., Cambridge, MA, United States.; Moderna, Inc., Cambridge, MA, United States.; Moderna, Inc., Cambridge, MA, United States.; Moderna, Inc., Cambridge, MA, United States.; Moderna, Inc., Cambridge, MA, United States.; Moderna, Inc., Cambridge, MA, United States.",Not Found
40247301,"Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer.",2025,Not Found,Not Found,yangting8506@qq.com.
40247100,Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023.,2025,Not Found,Not Found,Lee.Smith@aru.ac.uk.
40247005,Functional T cell response to COVID-19 vaccination with or without natural infection with SARS-CoV-2 in adults and children.,2025,Not Found,Not Found,rubhana@icddrb.org.
40246950,Ionizable lipid nanoparticles of mRNA vaccines elicit NF-ÎºB and IRF responses through toll-like receptor 4.,2025,Not Found,Not Found,allison.malloy@usuhs.edu.
40246777,Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer.,2025,Not Found,Not Found,Not Found
40246352,Immunobiology and immunotherapy of COVID-19.,2025,Kenneth Lundstrom,"PanTherapeutics, Rte de Lavaux 49, CH1095, Lutry, Switzerland. Electronic address: lundstromkenneth@gmail.com.",lundstromkenneth@gmail.com.
40243757,In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA Vaccines.,2025,Takaaki Hirotsu,"Hirotsu Bio Science Inc., Chiyoda-Ku, Tokyo 102-0094, Japan.",Not Found
40241379,Cyclic Acetal-Based Lipid Nanoparticles Deliver mRNA In Vivo for Tumor Immunotherapy.,2025,Honglei Zhang; Jingxuan Ma; Yuqing Ma; Lijie Jin; Jing Li; Gengshen Song,"Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing 100176, P. R. China.; Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing 100176, P. R. China.; Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing 100176, P. R. China.; Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing 100176, P. R. China.; Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing 100176, P. R. China.; Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing 100176, P. R. China.",Not Found
40241223,The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab.,2025,Not Found,Not Found,natbalandraud@gmail.com.
